Wellforce Selects Omnicell's Medication Management Automation and Diversion Prevention Solutions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Omnicell (OMCL) Misses Q3 EPS by 1c
October 27, 2016 5:39 PM EDTOmnicell (NASDAQ: OMCL) reported Q3 EPS of $0.40, $0.01 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $176.7 million versus the consensus estimate of $179.75 million.
"Omnicell completed another strong quarter marked by record revenues and market share gains," said Randall Lipps, Omnicell... More
